Learn how to stay healthy during COVID-19 with our free guide — Coronavirus: A guide to staying healthy (and sane) while stuck indoors

Studies related to and

A Randomized, Double-blind Placebo-controlled Trial Of Oral Creatine Monohydrate Augmentation For Enhanced Response To A Selective Serotonin Reuptake Inhibitor In Women With Major Depressive Disorder

Effect Decrease
Trial Design Double blind
Trial Length n/a
Number of Subjects 52
Sex n/a
Notes for this study:
5 g/day as adjunct therapy (alongside SSRIs) showed promise in reducing depression as assessed by the Hamilton Rating Scale for Depression (HRSD) and was safe over the 8 weeks the study lasted.

Full details on all 3 studies are available to Examine Plus members.

Already a member? Login now to access.